Pfizer has decided to withdraw its application for Emergency Use Authorisation of its Covid-19 vaccine in India.
A spokesperson of Pfizer said that in pursuance of the Emergency Use Authorisation of its Covid-19 vaccine, Pfizer participated in the Subject Expert Committee meeting of the Drug Regulatory Authority of India on February 3. “Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company have decided to withdraw its application at this time”, he said.
"Pfizer will continue to engage with the authority
and resubmit its approval request with additional information as it becomes
available in the near future. Pfizer remains committed to making its vaccine
available for use by the Government in India and to pursuing the requisite
pathway for emergency use authorisation that enables the availability of this
vaccine for any future deployment," the spokesperson added.